ADAM FARNUM: Open Payments
NPI 1871175638 · LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$605 in 36 payments from 11 companies in 2025. Trend: 2023 $232 · 2024 $274 · 2025 $605
Food & beverage: $605
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $230 |
| Novo Nordisk Inc | 6 | $136 |
| GlaxoSmithKline, LLC. | 2 | $49 |
| Lilly USA, LLC | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Amgen Inc. | 2 | $33 |
| Dynavax Technologies Corporation | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $14 |
| SANOFI PASTEUR INC. | 1 | $14 |
Products named: VRAYLAR, Rybelsus, TRELEGY ELLIPTA, MOUNJARO, Wegovy, QULIPTA, Kerendia, Ozempic.
Industry payments across MI — which companies pay providers there.
